Therapanacea SAS
About Therapanacea SAS
TheraPanacea SAS is a French healthcare AI company specializing in advanced software solutions designed to revolutionize cancer care, particularly in the field of radiotherapy. Their flagship product, ART-Plan™, is an AI-powered suite that optimizes various stages of the radiation oncology workflow, from treatment preparation to follow-up. This comprehensive system incorporates AI-based automatic delineation, intelligent image fusion (SmartFuse), MR-based pseudo-CT generation, and AI-enhanced tools for efficient and precise adaptive planning (AdaptBox). The aim is to standardize care, reduce inter-operator variability, and improve therapeutic accuracy, ultimately leading to better patient outcomes. ART-Plan™ is currently deployed in over 60 cancer centers across Europe, Africa, the Middle East, and the US, contributing to the care of more than 60,000 patients annually, with some sources indicating its use in over 100 centers globally.
In addition to radiotherapy solutions, TheraPanacea develops ART-Omics™, an AI-powered multi-modality biomarker discovery platform. This platform is designed to assist pharmaceutical companies in accelerating clinical research by leveraging AI for biomarker identification and seamlessly integrating these insights into clinical workflows as certified medical devices. The company’s core mission is to harness artificial intelligence, medical imaging, and advanced mathematics to drive innovation across healthcare. Their focus areas include improving treatment selection, planning, delivery, and outcomes, as well as patient stratification, with an expanding interest in neurology and other disease states. TheraPanacea’s solutions are geared towards delivering predictive, evidence-driven, and adaptive treatment planning, with the ultimate goal of enhancing the quality of life for cancer patients by enabling smarter treatment plans and reducing toxic side effects.
Focus Areas
Business Intelligence
| Key Investors | La French Tech, Biogen, EIT Health, Bpifrance, European Research Council |
| Partnerships | Brainlab, LAP, Stingray Healthcare, DYN'R Medical Systems, 2CRSi |
| Technology | Deep Learning, AI-based software platform, web-based solution, GPU workloads, multi-modal visualization, rigid and deformable registration |
| FDA Clearances | 4 cleared products (estimated) |
What Physicians Need to Know
For physicians, TheraPanacea's solutions, particularly ART-Planu2122, offer a transformative approach to radiotherapy. You can expect significant time savings in contouring (up to 93% and as fast as 3 minutes for full-body delineation), allowing more focus on complex treatment planning and patient interaction. The AI-powered automatic contouring provides expert-level accuracy and standardization, reducing inter-clinician variability and enhancing the consistency and reliability of treatment plans. The ability to generate pseudo-CTs from MRI and CBCT images streamlines workflows and improves patient comfort by facilitating MR-only radiotherapy. Furthermore, the AdaptBoxu2122 module provides objective metrics for adaptive therapy, aiding in crucial replanning decisions. The 'Plug and Play' nature ensures easy integration into existing workflows without the need for extensive data provision or training, and the web-based platform offers accessibility from anywhere within your clinic's network. This technology ultimately aims to deliver more precise, efficient, and personalized cancer care, backed by AI models trained on international guidelines and expert data.
TheraPanacea's ART-Planu2122 is designed for seamless integration with existing treatment planning systems (TPS) and PACS through DICOM exchange. They also have established partnerships, such as with Brainlab, to offer enhanced segmentation choices for clinicians. While currently server-based within the internal clinic network, future plans include cloud-based availability for further optimized and streamlined radiotherapy workflows.
Reviews & Opinions
Videos
News, demos, and interviews about Therapanacea SAS.
Videos load interactively. If none appear, search YouTube for Therapanacea SAS →
Press & Coverage
Frequently Asked Questions
Related Companies
QuickIntell is an AI-first healthcare technology company dedicated to transforming healthcare operations for physicians and healthcare providers. The company leverages advanced AI agents, including Computer Vision, Machine Learning, Optical Character Recognition (OCR), and Natural Language Processing (NLP), to streamline administrative workflows and enhance Revenue Cycle Management (RCM). QuickIntell’s solutions are designed to reduce administrative burden, […]
Ease Tax Relief, founded in 2016, is a tax relief and resolution company based in Harleysville, PA. The company specializes in helping individuals and small businesses resolve issues with the IRS, offering services such as Offer in Compromise, Partial Pay Installment Agreements, Payment Plans, and Penalty Reduction. Owned and operated by Zheng Yang, a CPA […]
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]